RU2013127881A - APPLICATION OF THE PHARMACEUTICAL COMPOSITION BASED ON THE SALT OF QUATERNARY PHOSPHONY AND SUBSTITUTED DINITROBENZOFUROXAN FOR THE TREATMENT OF Pyroplasmosis in Dogs and the Method of Treatment - Google Patents
APPLICATION OF THE PHARMACEUTICAL COMPOSITION BASED ON THE SALT OF QUATERNARY PHOSPHONY AND SUBSTITUTED DINITROBENZOFUROXAN FOR THE TREATMENT OF Pyroplasmosis in Dogs and the Method of Treatment Download PDFInfo
- Publication number
- RU2013127881A RU2013127881A RU2013127881/15A RU2013127881A RU2013127881A RU 2013127881 A RU2013127881 A RU 2013127881A RU 2013127881/15 A RU2013127881/15 A RU 2013127881/15A RU 2013127881 A RU2013127881 A RU 2013127881A RU 2013127881 A RU2013127881 A RU 2013127881A
- Authority
- RU
- Russia
- Prior art keywords
- treatment
- pyroplasmosis
- dogs
- pharmaceutical composition
- salt
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1. Применение фармацевтической композиции, содержащей н-тетрадецилтри-н-бутилфосфоний хлорид и 5,7-бис-(м-нитроанилино)-4,6-нитробензофуроксан в качестве активных компонентов при их весовом соотношении 1:10 и глюкозу как вспомогательное вещество, в качестве антипироплазмозного препарата для лечения пироплазмоза у собак.2. Способ по п.1, отличающийся тем, что препарат применяют перорально, два раза с интервалом 24 ч в дозе 350 мг/кг живого веса или 4 мг/кг в пересчете на действующее вещество - соль фосфония.1. The use of a pharmaceutical composition containing n-tetradecyltri-n-butylphosphonium chloride and 5,7-bis- (m-nitroanilino) -4,6-nitrobenzofuroxan as active components in a weight ratio of 1:10 and glucose as an excipient, as an anti-pyroplasmosis drug for treating pyroplasmosis in dogs. 2. The method according to claim 1, characterized in that the drug is administered orally, twice every 24 hours at a dose of 350 mg / kg live weight or 4 mg / kg in terms of the active substance - phosphonium salt.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2013127881/15A RU2548720C2 (en) | 2013-06-18 | 2013-06-18 | Application of pharmaceutical composition, based on salt of qurternary phosphonium and substituted dinitrobenzofuroxane for treatment of piroplasmosis in dogs and treatment method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2013127881/15A RU2548720C2 (en) | 2013-06-18 | 2013-06-18 | Application of pharmaceutical composition, based on salt of qurternary phosphonium and substituted dinitrobenzofuroxane for treatment of piroplasmosis in dogs and treatment method |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2013127881A true RU2013127881A (en) | 2014-12-27 |
RU2548720C2 RU2548720C2 (en) | 2015-04-20 |
Family
ID=53278415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2013127881/15A RU2548720C2 (en) | 2013-06-18 | 2013-06-18 | Application of pharmaceutical composition, based on salt of qurternary phosphonium and substituted dinitrobenzofuroxane for treatment of piroplasmosis in dogs and treatment method |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2548720C2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2750798C1 (en) * | 2020-10-26 | 2021-07-02 | Общество с ограниченной ответственностью "ФАРМАЦЕЯ" | Antinematodosis composition for veterinary medicine and method for its preparation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2347558C2 (en) * | 2006-06-01 | 2009-02-27 | Государственное научное учреждение Всероссийский научно-исследовательский институт экспериментальной ветеринарии имени Я.Р. Коваленко (ВИЭВ) | Medication for treatment of dog's pyroplasmosis |
RU2473334C2 (en) * | 2010-11-10 | 2013-01-27 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) Федеральный Университет" (ФГАОУ ВПО КФУ) | Anti-eimeriosis pharmaceutical composition based on salt of quarternary phosphonium and substituted dinitrobenzofuroxane |
-
2013
- 2013-06-18 RU RU2013127881/15A patent/RU2548720C2/en active
Also Published As
Publication number | Publication date |
---|---|
RU2548720C2 (en) | 2015-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1119490T1 (en) | PYRAZOLOPYROLIDINE PRODUCTS AND THEIR USE IN PATIENT TREATMENT | |
EA201592256A1 (en) | DERIVATIVES OF IMIDAZOPIRROLIDINONE AND THEIR APPLICATION IN THE TREATMENT OF DISEASES | |
EA201691151A1 (en) | CONNECTIONS FOR THE TREATMENT OF PATIENTS WITH ROS1-MUTANT CANCER CELLS | |
EA201692280A1 (en) | CONNECTIONS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY | |
EA201690069A1 (en) | THE USE OF HIGH DOSE PRIDOPIDINE FOR THE TREATMENT OF THE HANTINGTON'S DISEASE | |
EA201891103A1 (en) | COMPOSITIONS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY | |
EA201690287A1 (en) | 1,4-DESIGNED ANALOGUES OF PYRIDAZIN QUINOLINE AND METHODS OF TREATING CONDITIONS ASSOCIATED WITH SMN-DEFICIENCY | |
EA201592200A1 (en) | DERIVATIVES OF SULFAMOILPYRROLAMIDE AND THEIR APPLICATION AS MEDICINES FOR THE TREATMENT OF HEPATITIS B | |
TR201904455T4 (en) | 1,2,4-triazoles and their uses as nuclear transport modulators. | |
EA201590371A1 (en) | 1,4-DESIGNED PYRIDAZIN ANALOGUES AND METHODS OF TREATMENT RELATED TO SMN DEFICIENCY CONDITIONS | |
UA114907C2 (en) | Heterocyclyl compounds as mek inhibitors | |
EA201592255A1 (en) | DERIVATIVES OF PYRAZOLOPIRROLIDIN-4-IT AS A BET INHIBITOR AND THEIR APPLICATION IN THE TREATMENT OF THE DISEASE | |
EA201591363A1 (en) | TIADIAZOLE ANALOGUES AND METHODS OF TREATMENT OF STATES ASSOCIATED WITH SMN DEFICIENCY | |
EA201592254A1 (en) | DERIVATIVES OF Pyrazolopyrrolidin-4-IT and THEIR APPLICATION IN THE TREATMENT OF DISEASE | |
EA201591512A9 (en) | Boron-containing molecules, methods and compositions | |
EA201600434A1 (en) | APPLICATION OF DERIVATIVES OF BENZIMIDAZOLPROLINE | |
EA201692481A1 (en) | COMBINATION CONTAINING GLUCOCORTICOID AND EDO-S101 | |
EA201790726A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ULCERAL COLITIS | |
EA201591649A1 (en) | COMPOSITIONS WITH ORGANIC COMPOUNDS | |
EA201490045A1 (en) | DEUTERED 1-PIPERAZINO-3-PHENYLINDANES USED TO TREAT SCHIZOPHRENIA | |
EA201690974A1 (en) | HYDROMORPHONE AND NALOXONE FOR THE TREATMENT OF PAIN AND OPIOID-INITIATED INTESTINAL DYSFUNCTION SYNDROME | |
EA201590474A1 (en) | PHARMACEUTICAL COMPOSITION BASED ON COMPOSITE CAPSULES INCLUDING IRBESARTAN AND HMG-COA REDUCTASE INHIBITOR | |
EA201691058A1 (en) | DERIVATIVES OF PYRROLOPIRROLON AND THEIR APPLICATION FOR THE TREATMENT OF DISEASES | |
UA109544C2 (en) | PHARMACEUTICAL COMPOSITION CONTAINING PARACETAMOL AND METHOD OF MANUFACTURING | |
EA201591653A1 (en) | COMPOSITIONS FOR THE TREATMENT OF EYE DISORDERS USING DIPYRIDAMOL |